EVALUATION OF MEDICATION PROFILES OF HOSPITALIZED PATIENTS WITH CARDIOVASCULAR DISEASE
Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi · 20.04.2026 · 6 (1) · 32-42
DOI: 10.71255/maunsbd.1819196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi, online erschienen am 20.04.2026. Verfasst von Fatma Sablak und 1 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
This study aims to evaluate the medication use of patients hospitalized in the cardiology ward with different chronic conditions in addition to cardiovascular disease and to identify potential medication errors. The study included 110 patients who were admitted to the cardiology service of a public hospital in eastern Turkey, who were hospitalized for at least two days and who had additional chronic diseases. Information from the patients' medical records was analyzed and the diagnoses received during hospitalization were evaluated. Acute coronary syndrome (33.6%) was the most common reason for hospitalization, while 90% of the patients had hypertension. A total of 1061 drugs were prescribed to the patients participating in the study, with the most commonly prescribed drugs and drug groups being beta-blockers, proton pump inhibitors and antiplatelet agents. All drugs were evaluated for drug interactions and 1024 drug interactions were identified. The most common drugs found in interactions were acetylsalicylic acid and beta-blockers. A total of 89 criteria non-compliances were found in 42 patients evaluated under STOPP/START criteria. As a result of the medication appropriateness index analysis, the mean score of the medications was 9.89. Cardiovascular diseases are common diseases in the community and usually require the use of multiple drugs, so drug interactions are more common. It is important to evaluate the risk of drug interactions in patients using multiple drugs and to plan regular follow-up of patients due to possible side effects.
Zitieren
APA
Sablak, F., & Arslan, R. (2026). EVALUATION OF MEDICATION PROFILES OF HOSPITALIZED PATIENTS WITH CARDIOVASCULAR DISEASE. Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi, 6(1), 32-42. https://doi.org/10.71255/maunsbd.1819196
Vancouver
Sablak F, Arslan R. EVALUATION OF MEDICATION PROFILES OF HOSPITALIZED PATIENTS WITH CARDIOVASCULAR DISEASE. Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi. 2026;6(1):32-42. doi:10.71255/maunsbd.1819196
BibTeX
@article{Sablak2026,
author = {Sablak, Fatma and Arslan, Rana},
title = {EVALUATION OF MEDICATION PROFILES OF HOSPITALIZED PATIENTS WITH CARDIOVASCULAR DISEASE},
journal = {Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi},
year = {2026},
volume = {6},
number = {1},
pages = {32--42},
doi = {10.71255/maunsbd.1819196}
}
EUVIMED